Life AI Net
Accueil
Archives
Calculateurs
Annuaire
Newsletter
Hot
Connexion
Français
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Accueil
Archives
Calculateurs
Annuaire
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Connexion
Accueil
Archives
Calculateurs
Annuaire
More
Live
FierceBiotech
Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
Agilent
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Waters
Waters introduces biphenyl LC columns with low UV bleed and wide pH stability for improved aromatic separations - Chromatography Today
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com India
Lonza News
Acetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Thermo Fisher
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory
10x Genomics Blog
10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
FierceBiotech
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
FierceBiotech
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
FierceBiotech
Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
Agilent
Agilent Technologies, Inc. $A Shares Sold by OVERSEA CHINESE BANKING Corp Ltd - MarketBeat
Waters
Waters introduces biphenyl LC columns with low UV bleed and wide pH stability for improved aromatic separations - Chromatography Today
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com India
Lonza News
Acetylacetone Market: Asia Dominates with Lonza, Daicel, Wacker Boosting Specialty Chemicals Demand - openPR.com
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
Thermo Fisher
Thermo Fisher (TMO) Reports Q1: Everything You Need To Know Ahead Of Earnings - StockStory
10x Genomics Blog
10x Genomics: Atera Platform Launch Advances Spatial Biology With Single-Cell Resolution At Scale - Pulse 2.0
Lonza News
Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Australia
Illumina
CSR News Feed | Explore the latest corporate social responsibility news from Illumina - Illumina
FierceBiotech
AACR: Revolution sees pancreatic cancer win as 'tip of the iceberg' as RAS wave rises
FierceBiotech
Racing toward first FDA nod for autoimmune CAR-T, Kyverna bolsters lead with full SPS dataset
Archives
Rechercher
Rechercher
Récent
Plus ancien
Effacer
@BioWorld
Total
1062
Source
BioWorld
Recherche
--
BioWorld
24 févr. 2026
Astellas and Vir in $1.3B deal for CD3 T-cell engager
BioWorld
24 févr. 2026
Innovacell’s $91M Tokyo IPO to fund incontinence cell therapies
BioWorld
24 févr. 2026
Other news to note for Feb. 24, 2026
BioWorld
24 févr. 2026
Harbour Biomed spins out newco in $1.2B CTLA-4 deal
BioWorld
24 févr. 2026
Gilead-Genhouse's $1.5B+ deal boosts synthetic lethality push
BioWorld
24 févr. 2026
Appointments and advancements for Feb. 24, 2026
BioWorld
24 févr. 2026
Financings for Feb. 24, 2026
BioWorld
24 févr. 2026
In the clinic for Feb. 24, 2026
BioWorld
24 févr. 2026
Other news to note for Feb. 24, 2026
BioWorld
24 févr. 2026
Regulatory actions for Feb. 24, 2026
BioWorld
23 févr. 2026
Appointments and advancements for Feb. 23, 2026
BioWorld
23 févr. 2026
Financings for Feb. 23, 2026
BioWorld
23 févr. 2026
In the clinic for Feb. 23, 2026
BioWorld
23 févr. 2026
Other news to note for Feb. 23, 2026
BioWorld
23 févr. 2026
Regulatory actions for Feb. 23, 2026
BioWorld
23 févr. 2026
Gilead brings Arcellx fully under the fold
BioWorld
23 févr. 2026
Vanda gets FDA nod for atypical antipsychotic Bysanti
BioWorld
23 févr. 2026
Biggest gainers and losers for Feb. 16-20, 2026
Précédent
23 / 59
Suivant